ScholarLens Back to search
2004•Zhongguo yaofangRequires access

Clinical Observation on Combined Use of Urapidil Hydrochloride(Lixiding)and Dobutamine in Treatment of Severe Acute Congestive Heart Failure

Zou Guoding

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe the therapeutic effects of Lixiding(LXD)plus dobutamine(DBT)on severe acute congestive heart failure.METHODS:A total of40patients,including25patients with coronary heart disease,10hypertensive cardiopathy and5ectatic myocardiopathy,were enrolled in this study.Before and after combined use of LXD and DBT,the SBP,DBP,HR,CI,PCWP,TPR and LVEF were measured and the data obtained were detected with t test.RESULTS:After use of drugs,the SBP,DBP,HR,PCWP and TPR significantly decreased in comparison with those before medication(P 0.01),and CI and LVEF were significantly elevated(P0.01).CONCLUSION:There is obvious therapeutic efficacy of comˉbined use of LXD and DBT on severe acute congestive heart failure.

About this research paper

What this paper is about

OBJECTIVE:To observe the therapeutic effects of Lixiding(LXD)plus dobutamine(DBT)on severe acute congestive heart failure.METHODS:A total of40patients,including25patients with coronary heart disease,10hypertensive cardiopathy and5ectatic myocardiopathy,were enrolled in this study.Before and after combined use of LXD and DBT,the SBP,DBP,HR,CI,PCWP,TPR and LVEF were measured and the data obtained were detected with t test.RESULTS:After use of drugs,the SBP,DBP,HR,PCWP and TPR significantly decreased in comparison with those before medication(P 0.01),and CI and LVEF were significantly elevated(P0.01).CONCLUSION:There is obvious therapeutic efficacy of comˉbined use of LXD and DBT on severe acute congestive heart failure.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the therapeutic effects of Lixiding(LXD)plus dobutamine(DBT)on severe acute congestive heart failure.METHODS:A total of40patients,including25patients with coronary heart disease,10hypertensive cardiopathy and5ectatic myocardiopathy,were enrolled in this study.Before and after combined use of LXD and DBT,the SBP,DBP,HR,CI,PCWP,TPR and LVEF were measured and the data obtained were detected with t test.RESULTS:After use of drugs,the SBP,DBP,HR,PCWP and TPR significantly decreased in comparison with those before medication(P 0.01),and CI and LVEF were significantly elevated(P0.01).CONCLUSION:There is obvious therapeutic efficacy of comˉbined use of LXD and DBT on severe acute congestive heart failure.

Key concepts: Heart failure, Dobutamine, Medicine, Internal medicine, Cardiology, Ejection fraction, Hemodynamics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Observation on Combined Use of Urapidil Hydrochloride(Lixiding)and Dobutamine in Treatment of Severe Acute Congestive Heart Failure — Research Paper | ScholarLens